Generic placeholder image

Letters in Drug Design & Discovery

Editor-in-Chief

ISSN (Print): 1570-1808
ISSN (Online): 1875-628X

Research Article

Computational Insights on Migraine and Anxiety in Association with BDNF

Author(s): Sakthi Sasikala Sundaravel, Beena Briget Kuriakose, Sakeena Mushfiq and Karthikeyan Muthusamy*

Volume 21, Issue 16, 2024

Published on: 02 February, 2024

Page: [3389 - 3407] Pages: 19

DOI: 10.2174/0115701808274096231207042744

Price: $65

Abstract

Background: Migraine is an unusual piercing headache on one side of the head. It is due to the dysregulation of epigenetic factors associated with the brain. Migraine affects about one percent of the general population. Despite the recent implementation of worldwide diagnostic criteria for migraine, this disorder remains relatively unknown and is frequently underdiagnosed. Migrainous conditions are also associated with anxiety and stress. This pathologic condition affects the daily life and productivity of the patients.

Objective: Hence, there is a need to develop proper treatment and management strategies to cope with migraine and associated anxiety. Through in silico approaches, this work elucidates to identify the effective lead compounds for migraine and anxiety.

Methods: Brain-derived neurotrophic factor (BDNF) was identified as a possible target for treating migraine and anxiety using computational analysis. Virtual screening and molecular dynamics simulation were used to find potential agonists with high affinities for BDNF.

Results: Based on the results of computational analysis (glide XP score, number of interactions, glide energy, and pharmacokinetic factors), four top hit molecules (Asinex_35922, Enamine_44630, Maybridge_1999, and SMMDB_17457) were identified and taken for further analysis. The hydrogen bond interactions between the agonists and the BDNF protein were verified by dynamics analysis

Conclusion: Computational studies support that BDNF agonist molecules could be effective regulating molecules for migraine and anxiety. For further evidence of the effectiveness of lead compounds in treating migraine and related anxiety, more experimental studies are necessary.

Keywords: Migraine, anxiety, structure-based virtual screening, ADME/T predictions, DFT analysis, molecular dynamics simulations.

Graphical Abstract
[1]
Goadsby, P.J.; Lipton, R.B.; Ferrari, M.D. Migraine--current understanding and treatment. N. Engl. J. Med., 2002, 346(4), 257-270.
[http://dx.doi.org/10.1056/NEJMra010917] [PMID: 11807151]
[2]
Vos, T.; Barber, R.M.; Bell, B.; Bertozzi-Villa, A.; Biryukov, S.; Bolliger, I.; Charlson, F.; Davis, A.; Degenhardt, L.; Dicker, D.; Duan, L.; Erskine, H.; Feigin, V.L.; Ferrari, A.J.; Fitzmaurice, C.; Fleming, T.; Graetz, N.; Guinovart, C.; Haagsma, J.; Hansen, G.M.; Hanson, S.W.; Heuton, K.R.; Higashi, H.; Kassebaum, N.; Kyu, H.; Laurie, E.; Liang, X.; Lofgren, K.; Lozano, R.; MacIntyre, M.F.; Moradi-Lakeh, M.; Naghavi, M.; Nguyen, G.; Odell, S.; Ortblad, K.; Roberts, D.A.; Roth, G.A.; Sandar, L.; Serina, P.T.; Stanaway, J.D.; Steiner, C.; Thomas, B.; Vollset, S.E.; Whiteford, H.; Wolock, T.M.; Ye, P.; Zhou, M.; Ãvila, M.A.; Aasvang, G.M.; Abbafati, C.; Ozgoren, A.A.; Abd-Allah, F.; Aziz, M.I.A.; Abera, S.F.; Aboyans, V.; Abraham, J.P.; Abraham, B.; Abubakar, I.; Abu-Raddad, L.J.; Abu-Rmeileh, N.M.E.; Aburto, T.C.; Achoki, T.; Ackerman, I.N.; Adelekan, A.; Ademi, Z.; Adou, A.K.; Adsuar, J.C.; Arnlov, J.; Agardh, E.E.; Al Khabouri, M.J.; Alam, S.S.; Alasfoor, D.; Albittar, M.I.; Alegretti, M.A.; Aleman, A.V.; Alemu, Z.A.; Alfonso-Cristancho, R.; Alhabib, S.; Ali, R.; Alla, F.; Allebeck, P.; Allen, P.J.; AlMazroa, M.A.A.; Alsharif, U.; Alvarez, E.; Alvis-Guzman, N.; Ameli, O.; Amini, H.; Ammar, W.; Anderson, B.O.; Anderson, H.R.; Antonio, C.A.T.; Anwari, P.; Apfel, H.; Arsenijevic, V.S.A.; Artaman, A.; Asghar, R.J.; Assadi, R.; Atkins, L.S.; Atkinson, C.; Badawi, A.; Bahit, M.C.; Bakfalouni, T.; Balakrishnan, K.; Balalla, S.; Banerjee, A.; Barker-Collo, S.L.; Barquera, S.; Barregard, L.; Barrero, L.H.; Basu, S.; Basu, A.; Baxter, A.; Beardsley, J.; Bedi, N.; Beghi, E.; Bekele, T.; Bell, M.L.; Benjet, C.; Bennett, D.A.; Bensenor, I.M.; Benzian, H.; Bernabe, E.; Beyene, T.J.; Bhala, N.; Bhalla, A.; Bhutta, Z.; Bienhoff, K.; Bikbov, B.; Abdulhak, A.B.; Blore, J.D.; Blyth, F.M.; Bohensky, M.A.; Basara, B.B.; Borges, G.; Bornstein, N.M.; Bose, D.; Boufous, S.; Bourne, R.R.; Boyers, L.N.; Brainin, M.; Brauer, M.; Brayne, C.E.G.; Brazinova, A.; Breitborde, N.J.K.; Brenner, H.; Briggs, A.D.M.; Brooks, P.M.; Brown, J.; Brugha, T.S.; Buchbinder, R.; Buckle, G.C.; Bukhman, G.; Bulloch, A.G.; Burch, M.; Burnett, R.; Cardenas, R.; Cabral, N.L.; Nonato, I.R.C.; Campuzano, J.C.; Carapetis, J.R.; Carpenter, D.O.; Caso, V.; Castaneda-Orjuela, C.A.; Catala-Lopez, F.; Chadha, V.K.; Chang, J-C.; Chen, H.; Chen, W.; Chiang, P.P.; Chimed-Ochir, O.; Chowdhury, R.; Christensen, H.; Christophi, C.A.; Chugh, S.S.; Cirillo, M.; Coggeshall, M.; Cohen, A.; Colistro, V.; Colquhoun, S.M.; Contreras, A.G.; Cooper, L.T.; Cooper, C.; Cooperrider, K.; Coresh, J.; Cortinovis, M.; Criqui, M.H.; Crump, J.A.; Cuevas-Nasu, L.; Dandona, R.; Dandona, L.; Dansereau, E.; Dantes, H.G.; Dargan, P.I.; Davey, G.; Davitoiu, D.V.; Dayama, A.; De la Cruz-Gongora, V.; de la Vega, S.F.; De Leo, D.; del Pozo-Cruz, B.; Dellavalle, R.P.; Deribe, K.; Derrett, S.; Des Jarlais, D.C.; Dessalegn, M.; deVeber, G.A.; Dharmaratne, S.D.; Diaz-Torne, C.; Ding, E.L.; Dokova, K.; Dorsey, E.R.; Driscoll, T.R.; Duber, H.; Durrani, A.M.; Edmond, K.M.; Ellenbogen, R.G.; Endres, M.; Ermakov, S.P.; Eshrati, B.; Esteghamati, A.; Estep, K.; Fahimi, S.; Farzadfar, F.; Fay, D.F.J.; Felson, D.T.; Fereshtehnejad, S-M.; Fernandes, J.G.; Ferri, C.P.; Flaxman, A.; Foigt, N.; Foreman, K.J.; Fowkes, F.G.R.; Franklin, R.C.; Furst, T.; Futran, N.D.; Gabbe, B.J.; Gankpe, F.G.; Garcia-Guerra, F.A.; Geleijnse, J.M.; Gessner, B.D.; Gibney, K.B.; Gillum, R.F.; Ginawi, I.A.; Giroud, M.; Giussani, G.; Goenka, S.; Goginashvili, K.; Gona, P.; de Cosio, T.G.; Gosselin, R.A.; Gotay, C.C.; Goto, A.; Gouda, H.N.; Guerrant, R.; Gugnani, H.C.; Gunnell, D.; Gupta, R.; Gupta, R.; Gutierrez, R.A.; Hafezi-Nejad, N.; Hagan, H.; Halasa, Y.; Hamadeh, R.R.; Hamavid, H.; Hammami, M.; Hankey, G.J.; Hao, Y.; Harb, H.L.; Haro, J.M.; Havmoeller, R.; Hay, R.J.; Hay, S.; Hedayati, M.T.; Pi, I.B.H.; Heydarpour, P.; Hijar, M.; Hoek, H.W.; Hoffman, H.J.; Hornberger, J.C.; Hosgood, H.D.; Hossain, M.; Hotez, P.J.; Hoy, D.G.; Hsairi, M.; Hu, H.; Hu, G.; Huang, J.J.; Huang, C.; Huiart, L.; Husseini, A.; Iannarone, M.; Iburg, K.M.; Innos, K.; Inoue, M.; Jacobsen, K.H.; Jassal, S.K.; Jeemon, P.; Jensen, P.N.; Jha, V.; Jiang, G.; Jiang, Y.; Jonas, J.B.; Joseph, J.; Juel, K.; Kan, H.; Karch, A.; Karimkhani, C.; Karthikeyan, G.; Katz, R.; Kaul, A.; Kawakami, N.; Kazi, D.S.; Kemp, A.H.; Kengne, A.P.; Khader, Y.S.; Khalifa, S.E.A.H.; Khan, E.A.; Khan, G.; Khang, Y-H.; Khonelidze, I.; Kieling, C.; Kim, D.; Kim, S.; Kimokoti, R.W.; Kinfu, Y.; Kinge, J.M.; Kissela, B.M.; Kivipelto, M.; Knibbs, L.; Knudsen, A.K.; Kokubo, Y.; Kosen, S.; Kramer, A.; Kravchenko, M.; Krishnamurthi, R.V.; Krishnaswami, S.; Defo, B.K.; Bicer, B.K.; Kuipers, E.J.; Kulkarni, V.S.; Kumar, K.; Kumar, G.A.; Kwan, G.F.; Lai, T.; Lalloo, R.; Lam, H.; Lan, Q.; Lansingh, V.C.; Larson, H.; Larsson, A.; Lawrynowicz, A.E.B.; Leasher, J.L.; Lee, J-T.; Leigh, J.; Leung, R.; Levi, M.; Li, B.; Li, Y.; Li, Y. liang, J.; Lim, S.; Lin, H-H.; Lind, M.; Lindsay, M.P.; Lipshultz, S.E.; Liu, S.; Lloyd, B.K.; Ohno, S.L.; Logroscino, G.; Looker, K.J.; Lopez, A.D.; Lopez-Olmedo, N.; Lortet-Tieulent, J.; Lotufo, P.A.; Low, N.; Lucas, R.M.; Lunevicius, R.; Lyons, R.A.; Ma, J.; Ma, S.; Mackay, M.T.; Majdan, M.; Malekzadeh, R.; Mapoma, C.C.; Marcenes, W.; March, L.M.; Margono, C.; Marks, G.B.; Marzan, M.B.; Masci, J.R.; Mason-Jones, A.J.; Matzopoulos, R.G.; Mayosi, B.M.; Mazorodze, T.T.; McGill, N.W.; McGrath, J.J.; McKee, M.; McLain, A.; McMahon, B.J.; Meaney, P.A.; Mehndiratta, M.M.; Mejia-Rodriguez, F.; Mekonnen, W.; Melaku, Y.A.; Meltzer, M.; Memish, Z.A.; Mensah, G.; Meretoja, A.; Mhimbira, F.A.; Micha, R.; Miller, T.R.; Mills, E.J.; Mitchell, P.B.; Mock, C.N.; Moffitt, T.E.; Ibrahim, N.M.; Mohammad, K.A.; Mokdad, A.H.; Mola, G.L.; Monasta, L.; Montico, M.; Montine, T.J.; Moore, A.R.; Moran, A.E.; Morawska, L.; Mori, R.; Moschandreas, J.; Moturi, W.N.; Moyer, M.; Mozaffarian, D.; Mueller, U.O.; Mukaigawara, M.; Murdoch, M.E.; Murray, J.; Murthy, K.S.; Naghavi, P.; Nahas, Z.; Naheed, A.; Naidoo, K.S.; Naldi, L.; Nand, D.; Nangia, V.; Narayan, K.M.V.; Nash, D.; Nejjari, C.; Neupane, S.P.; Newman, L.M.; Newton, C.R.; Ng, M.; Ngalesoni, F.N.; Nhung, N.T.; Nisar, M.I.; Nolte, S.; Norheim, O.F.; Norman, R.E.; Norrving, B.; Nyakarahuka, L.; Oh, I.H.; Ohkubo, T.; Omer, S.B.; Opio, J.N.; Ortiz, A.; Pandian, J.D.; Panelo, C.I.A.; Papachristou, C.; Park, E-K.; Parry, C.D.; Caicedo, A.J.P.; Patten, S.B.; Paul, V.K.; Pavlin, B.I.; Pearce, N.; Pedraza, L.S.; Pellegrini, C.A.; Pereira, D.M.; Perez-Ruiz, F.P.; Perico, N.; Pervaiz, A.; Pesudovs, K.; Peterson, C.B.; Petzold, M.; Phillips, M.R.; Phillips, D.; Phillips, B.; Piel, F.B.; Plass, D.; Poenaru, D.; Polanczyk, G.V.; Polinder, S.; Pope, C.A.; Popova, S.; Poulton, R.G.; Pourmalek, F.; Prabhakaran, D.; Prasad, N.M.; Qato, D.; Quistberg, D.A.; Rafay, A.; Rahimi, K.; Rahimi-Movaghar, V.; Rahman, S.; Raju, M.; Rakovac, I.; Rana, S.M.; Razavi, H.; Refaat, A.; Rehm, J.; Remuzzi, G.; Resnikoff, S.; Ribeiro, A.L.; Riccio, P.M.; Richardson, L.; Richardus, J.H.; Riederer, A.M.; Robinson, M.; Roca, A.; Rodriguez, A.; Rojas-Rueda, D.; Ronfani, L.; Rothenbacher, D.; Roy, N.; Ruhago, G.M.; Sabin, N.; Sacco, R.L.; Ksoreide, K.; Saha, S.; Sahathevan, R.; Sahraian, M.A.; Sampson, U.; Sanabria, J.R.; Sanchez-Riera, L.; Santos, I.S.; Satpathy, M.; Saunders, J.E.; Sawhney, M.; Saylan, M.I.; Scarborough, P.; Schoettker, B.; Schneider, I.J.C.; Schwebel, D.C.; Scott, J.G.; Seedat, S.; Sepanlou, S.G.; Serdar, B.; Servan-Mori, E.E.; Shackelford, K.; Shaheen, A.; Shahraz, S.; Levy, T.S.; Shangguan, S.; She, J.; Sheikhbahaei, S.; Shepard, D.S.; Shi, P.; Shibuya, K.; Shinohara, Y.; Shiri, R.; Shishani, K.; Shiue, I.; Shrime, M.G.; Sigfusdottir, I.D.; Silberberg, D.H.; Simard, E.P.; Sindi, S.; Singh, J.A.; Singh, L.; Skirbekk, V.; Sliwa, K.; Soljak, M.; Soneji, S.; Soshnikov, S.S.; Speyer, P.; Sposato, L.A.; Sreeramareddy, C.T.; Stoeckl, H.; Stathopoulou, V.K.; Steckling, N.; Stein, M.B.; Stein, D.J.; Steiner, T.J.; Stewart, A.; Stork, E.; Stovner, L.J.; Stroumpoulis, K.; Sturua, L.; Sunguya, B.F.; Swaroop, M.; Sykes, B.L.; Tabb, K.M.; Takahashi, K.; Tan, F.; Tandon, N.; Tanne, D.; Tanner, M.; Tavakkoli, M.; Taylor, H.R.; Te Ao, B.J.; Temesgen, A.M.; Have, M.T.; Tenkorang, E.Y.; Terkawi, A.S.; Theadom, A.M.; Thomas, E.; Thorne-Lyman, A.L.; Thrift, A.G.; Tleyjeh, I.M.; Tonelli, M.; Topouzis, F.; Towbin, J.A.; Toyoshima, H.; Traebert, J.; Tran, B.X.; Trasande, L.; Trillini, M.; Truelsen, T.; Trujillo, U.; Tsilimbaris, M.; Tuzcu, E.M.; Ukwaja, K.N.; Undurraga, E.A.; Uzun, S.B.; van Brakel, W.H.; van de Vijver, S.; Dingenen, R.V.; van Gool, C.H.; Varakin, Y.Y.; Vasankari, T.J.; Vavilala, M.S.; Veerman, L.J.; Velasquez-Melendez, G.; Venketasubramanian, N.; Vijayakumar, L.; Villalpando, S.; Violante, F.S.; Vlassov, V.V.; Waller, S.; Wallin, M.T.; Wan, X.; Wang, L.; Wang, J.L.; Wang, Y.; Warouw, T.S.; Weichenthal, S.; Weiderpass, E.; Weintraub, R.G.; Werdecker, A.; Wessells, K.R.R.; Westerman, R.; Wilkinson, J.D.; Williams, H.C.; Williams, T.N.; Woldeyohannes, S.M.; Wolfe, C.D.A.; Wong, J.Q.; Wong, H.; Woolf, A.D.; Wright, J.L.; Wurtz, B.; Xu, G.; Yang, G.; Yano, Y.; Yenesew, M.A.; Yentur, G.K.; Yip, P.; Yonemoto, N.; Yoon, S-J.; Younis, M.; Yu, C.; Kim, K.Y.; Zaki, M.E.S.; Zhang, Y.; Zhao, Z.; Zhao, Y.; Zhu, J.; Zonies, D.; Zunt, J.R.; Salomon, J.A.; Murray, C.J.L. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet, 2015, 386(9995), 743-800.
[http://dx.doi.org/10.1016/S0140-6736(15)60692-4] [PMID: 26063472]
[3]
Buse, D.C.; Manack, A.; Serrano, D.; Turkel, C.; Lipton, R.B. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J. Neurol. Neurosurg. Psychiatry, 2010, 81(4), 428-432.
[http://dx.doi.org/10.1136/jnnp.2009.192492] [PMID: 20164501]
[4]
Amiri, P.; Kazeminasab, S.; Nejadghaderi, S.A.; Mohammadinasab, R.; Pourfathi, H.; Araj-Khodaei, M.; Sullman, M.J.M.; Kolahi, A-A.; Safiri, S. Migraine: A review on its history, global epidemiology, risk factors, and comorbidities. Front. Neurol., 2022, 12, 800605.
[http://dx.doi.org/10.3389/fneur.2021.800605]
[5]
Giffin, N.J.; Ruggiero, L.; Lipton, R.B.; Silberstein, S.D.; Tvedskov, J.F.; Olesen, J.; Altman, J.; Goadsby, P.J.; Macrae, A. Premonitory symptoms in migraine: An electronic diary study. Neurology, 2003, 60(6), 935-940.
[http://dx.doi.org/10.1212/01.WNL.0000052998.58526.A9] [PMID: 12654956]
[6]
Giffin, N.J.; Lipton, R.B.; Silberstein, S.D.; Olesen, J.; Goadsby, P.J. The migraine postdrome. Neurology, 2016, 87(3), 309-313.
[http://dx.doi.org/10.1212/WNL.0000000000002789] [PMID: 27335112]
[7]
Kelman, L. The postdrome of the acute migraine attack. Cephalalgia, 2006, 26(2), 214-220.
[http://dx.doi.org/10.1111/j.1468-2982.2005.01026.x] [PMID: 16426278]
[8]
Rasmussen, B.K.; Olesen, J. Migraine with aura and migraine without aura: An epidemiological study. Cephalalgia, 1992, 12(4), 221-228.
[http://dx.doi.org/10.1046/j.1468-2982.1992.1204221.x] [PMID: 1525797]
[9]
Markowitz, S.; Saito, K.; Moskowitz, M.A. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J. Neurosci., 1987, 7(12), 4129-4136.
[http://dx.doi.org/10.1523/JNEUROSCI.07-12-04129.1987] [PMID: 3694267]
[10]
Radat, F.; Swendsen, J. Psychiatric comorbidity in migraine: A review. Cephalalgia, 2005, 25(3), 165-178.
[http://dx.doi.org/10.1111/j.1468-2982.2004.00839.x] [PMID: 15689191]
[11]
Antonaci, F.; Nappi, G.; Galli, F.; Manzoni, G.C.; Calabresi, P.; Costa, A. Migraine and psychiatric comorbidity: A review of clinical findings. J. Headache Pain, 2011, 12(2), 115-125.
[http://dx.doi.org/10.1007/s10194-010-0282-4] [PMID: 21210177]
[12]
Dresler, T.; Caratozzolo, S.; Guldolf, K.; Huhn, J.I.; Loiacono, C.; Niiberg-Pikksööt, T.; Puma, M.; Sforza, G.; Tobia, A.; Ornello, R.; Serafini, G. Understanding the nature of psychiatric comorbidity in migraine: A systematic review focused on interactions and treatment implications. J. Headache Pain, 2019, 20(1), 51.
[http://dx.doi.org/10.1186/s10194-019-0988-x] [PMID: 31072313]
[13]
Lampl, C.; Thomas, H.; Tassorelli, C.; Katsarava, Z.; Laínez, J.M.; Lantéri-Minet, M.; Rastenyte, D.; de la Torre, R.E.; Stovner, L.J.; Andrée, C.; Steiner, T.J. Headache, depression and anxiety: Associations in the Eurolight project. J. Headache Pain, 2016, 17(1), 59.
[http://dx.doi.org/10.1186/s10194-016-0649-2] [PMID: 27245683]
[14]
Karimi, L.; Crewther, S.G.; Wijeratne, T.; Evans, A.E.; Afshari, L.; Khalil, H. The prevalence of migraine with anxiety among genders. Front. Neurol., 2020, 11, 1252.
[http://dx.doi.org/10.3389/fneur.2020.569405]
[15]
Blumenfeld, A.M.; Varon, S.F.; Wilcox, T.K.; Buse, D.C.; Kawata, A.K.; Manack, A.; Goadsby, P.J.; Lipton, R.B. Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS). Cephalalgia, 2011, 31(3), 301-315.
[http://dx.doi.org/10.1177/0333102410381145] [PMID: 20813784]
[16]
Zwart, J.A.; Dyb, G.; Hagen, K.; Ødegård, K.J.; Dahl, A.A.; Bovim, G.; Stovner, L.J. Depression and anxiety disorders associated with headache frequency. The Nord‐Trøndelag Health Study. Eur. J. Neurol., 2003, 10(2), 147-152.
[http://dx.doi.org/10.1046/j.1468-1331.2003.00551.x] [PMID: 12603289]
[17]
Zebenholzer, K.; Lechner, A.; Broessner, G.; Lampl, C.; Luthringshausen, G.; Wuschitz, A.; Obmann, S.M.; Berek, K.; Wöber, C. Impact of depression and anxiety on burden and management of episodic and chronic headaches – a cross-sectional multicentre study in eight Austrian headache centres. J. Headache Pain, 2016, 17(1), 15.
[http://dx.doi.org/10.1186/s10194-016-0603-3] [PMID: 26920681]
[18]
Pesa, J.; Lage, M.J. The medical costs of migraine and comorbid anxiety and depression. Headache, 2004, 44(6), 562-570.
[http://dx.doi.org/10.1111/j.1526-4610.2004.446004.x] [PMID: 15186300]
[19]
Alonso, J.; Liu, Z.; Evans-Lacko, S.; Sadikova, E.; Sampson, N.; Chatterji, S.; Abdulmalik, J.; Aguilar-Gaxiola, S.; Al-Hamzawi, A.; Andrade, L.H.; Bruffaerts, R.; Cardoso, G.; Cia, A.; Florescu, S.; de Girolamo, G.; Gureje, O.; Haro, J.M.; He, Y.; de Jonge, P.; Karam, E.G.; Kawakami, N.; Kovess-Masfety, V.; Lee, S.; Levinson, D.; Medina-Mora, M.E.; Navarro-Mateu, F.; Pennell, B.E.; Piazza, M.; Posada-Villa, J.; ten Have, M.; Zarkov, Z.; Kessler, R.C.; Thornicroft, G. Treatment gap for anxiety disorders is global: Results of the world mental health surveys in 21 countries. Depress. Anxiety, 2018, 35(3), 195-208.
[http://dx.doi.org/10.1002/da.22711] [PMID: 29356216]
[20]
Santomauro, D.F.; Mantilla Herrera, A.M.; Shadid, J.; Zheng, P.; Ashbaugh, C.; Pigott, D.M.; Abbafati, C.; Adolph, C.; Amlag, J.O.; Aravkin, A.Y.; Bang-Jensen, B.L.; Bertolacci, G.J.; Bloom, S.S.; Castellano, R.; Castro, E.; Chakrabarti, S.; Chattopadhyay, J.; Cogen, R.M.; Collins, J.K.; Dai, X.; Dangel, W.J.; Dapper, C.; Deen, A.; Erickson, M.; Ewald, S.B.; Flaxman, A.D.; Frostad, J.J.; Fullman, N.; Giles, J.R.; Giref, A.Z.; Guo, G.; He, J.; Helak, M.; Hulland, E.N.; Idrisov, B.; Lindstrom, A.; Linebarger, E.; Lotufo, P.A.; Lozano, R.; Magistro, B.; Malta, D.C.; Månsson, J.C.; Marinho, F.; Mokdad, A.H.; Monasta, L.; Naik, P.; Nomura, S.; O’Halloran, J.K.; Ostroff, S.M.; Pasovic, M.; Penberthy, L.; Reiner, R.C., Jr; Reinke, G.; Ribeiro, A.L.P.; Sholokhov, A.; Sorensen, R.J.D.; Varavikova, E.; Vo, A.T.; Walcott, R.; Watson, S.; Wiysonge, C.S.; Zigler, B.; Hay, S.I.; Vos, T.; Murray, C.J.L.; Whiteford, H.A.; Ferrari, A.J. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet, 2021, 398(10312), 1700-1712.
[http://dx.doi.org/10.1016/S0140-6736(21)02143-7] [PMID: 34634250]
[21]
Nutt, D.; Argyropoulos, S.; Hood, S.; Potokar, J. Generalized anxiety disorder: A comorbid disease. Eur Neuropsychopharmacol, 2006, 16(S2), S109-S118.16.
[http://dx.doi.org/10.1016/j.euroneuro.2006.04.003 ]
[22]
Buoli, M.; Caldiroli, A.; Caletti, E.; Paoli, R.A.; Altamura, A.C. New approaches to the pharmacological management of generalized anxiety disorder. Expert Opin. Pharmacother., 2013, 14(2), 175-184.
[http://dx.doi.org/10.1517/14656566.2013.759559] [PMID: 23282069]
[23]
Bandelow, B.; Zohar, J.; Hollander, E.; Kasper, S.; Möller, H.J.; Bandelow, B.; Zohar, J.; Hollander, E.; Kasper, S.; Möller, H-J.; Allgulander, C.; Ayuso-Gutierrez, J.; Baldwin, D.S.; Buenvicius, R.; Cassano, G.; Fineberg, N.; Gabriels, L.; Hindmarch, I.; Kaiya, H.; Klein, D.F.; Lader, M.; Lecrubier, Y.; Lépine, J.P.; Liebowitz, M.R.; Lopez-Ibor, J.J.; Marazziti, D.; Miguel, E.C.; Oh, K.S.; Preter, M.; Rupprecht, R.; Sato, M.; Starcevic, V.; Stein, D.J.; van Ameringen, M.; Vega, J. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J. Biol. Psychiatry, 2008, 9(4), 248-312.
[http://dx.doi.org/10.1080/15622970802465807] [PMID: 18949648]
[24]
Möhler, H. GABAA receptor diversity and pharmacology. Cell Tissue Res., 2006, 326(2), 505-516.
[http://dx.doi.org/10.1007/s00441-006-0284-3] [PMID: 16937111]
[25]
Uusi-Oukari, M.; Korpi, E.R. Regulation of GABA(A) receptor subunit expression by pharmacological agents. Pharmacol. Rev., 2010, 62(1), 97-135.
[http://dx.doi.org/10.1124/pr.109.002063] [PMID: 20123953]
[26]
Menif, L.; Oueslati, B.; Maamri, A.; Melki, W.; Zalila, H. Correlates of benzodiazepine dependence in patients with depression followed up in a psychiatric outpatient unit in Tunisia. J. Ethn. Subst. Abuse, 2021, 20(1), 104-116.
[http://dx.doi.org/10.1080/15332640.2019.1589611] [PMID: 30983538]
[27]
Bao, X.; Ye, T.; Wang, X.; Han, L.; Wang, T.; Qi, D.; Wang, X.; Cheng, X-R. The molecular mechanisms of suanzaoren prescription for anti-anxiety were investigated based on network pharmacology. Research Square, 2021.
[http://dx.doi.org/10.21203/rs.3.rs-719079/v1]
[28]
Dolati, S.; Rikhtegar, R.; Mehdizadeh, A.; Yousefi, M. The role of magnesium in pathophysiology and migraine treatment. Biol. Trace Elem. Res., 2020, 196(2), 375-383.
[http://dx.doi.org/10.1007/s12011-019-01931-z] [PMID: 31691193]
[29]
Levi-Montalcini, R.; Hamburger, V. Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J. Exp. Zool., 1951, 116(2), 321-361.
[http://dx.doi.org/10.1002/jez.1401160206] [PMID: 14824426]
[30]
Barde, Y.A.; Edgar, D.; Thoenen, H. Purification of a new neurotrophic factor from mammalian brain. EMBO J., 1982, 1(5), 549-553.
[http://dx.doi.org/10.1002/j.1460-2075.1982.tb01207.x] [PMID: 7188352]
[31]
Maisonpierre, P.C.; Belluscio, L.; Squinto, S.; Ip, N.Y.; Furth, M.E.; Lindsay, R.M.; Yancopoulos, G.D. Neurotrophin-3: A neurotrophic factor related to NGF and BDNF. Science, 1990, 247(4949), 1446-1451.
[http://dx.doi.org/10.1126/science.2321006] [PMID: 2321006]
[32]
Hallböök, F.; Ibáñez, C.F.; Persson, H. Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in xenopus ovary. Neuron, 1991, 6(5), 845-858.
[http://dx.doi.org/10.1016/0896-6273(91)90180-8] [PMID: 2025430]
[33]
Ip, N.Y.; Ibáñez, C.F.; Nye, S.H.; McClain, J.; Jones, P.F.; Gies, D.R.; Belluscio, L.; Le Beau, M.M.; Espinosa, R., III; Squinto, S.P. Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution, and receptor specificity. Proc. Natl. Acad. Sci. USA, 1992, 89(7), 3060-3064.
[http://dx.doi.org/10.1073/pnas.89.7.3060] [PMID: 1313578]
[34]
Binder, D.K.; Scharfman, H.E. Brain-derived neurotrophic factor. Growth Factors, 2004, 22(3), 123-131.
[http://dx.doi.org/10.1080/08977190410001723308] [PMID: 15518235]
[35]
Levi-Montalcini, R. The nerve growth factor: Its mode of action on sensory and sympathetic nerve cells. Harvey Lect., 1966, 60, 217-259.
[36]
Hohn, A.; Leibrock, J.; Bailey, K.; Barde, Y.A. Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature, 1990, 344(6264), 339-341.
[http://dx.doi.org/10.1038/344339a0] [PMID: 2314473]
[37]
Metsis, M.; Timmusk, T.; Arenas, E.; Persson, H. Differential usage of multiple brain-derived neurotrophic factor promoters in the rat brain following neuronal activation. Proc. Natl. Acad. Sci., 1993, 90(19), 8802-8806.
[http://dx.doi.org/10.1073/pnas.90.19.8802] [PMID: 8415610]
[38]
Timmusk, T.; Palm, K.; Metsis, M.; Reintam, T.; Paalme, V.; Saarma, M.; Persson, H. Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron, 1993, 10(3), 475-489.
[http://dx.doi.org/10.1016/0896-6273(93)90335-O] [PMID: 8461137]
[39]
Tanaka, J.; Horiike, Y.; Matsuzaki, M.; Miyazaki, T.; Ellis-Davies, G.C.R.; Kasai, H. Protein synthesis and neurotrophin-dependent structural plasticity of single dendritic spines. Science, 2008, 319(5870), 1683-1687.
[http://dx.doi.org/10.1126/science.1152864] [PMID: 18309046]
[40]
Horch, H.W.; Katz, L.C. BDNF release from single cells elicits local dendritic growth in nearby neurons. Nat. Neurosci., 2002, 5(11), 1177-1184.
[http://dx.doi.org/10.1038/nn927] [PMID: 12368805]
[41]
Figurov, A.; Pozzo-Miller, L.D.; Olafsson, P.; Wang, T.; Lu, B. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature, 1996, 381(6584), 706-709.
[http://dx.doi.org/10.1038/381706a0] [PMID: 8649517]
[42]
Kang, H.; Schuman, E.M. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science, 1995, 267(5204), 1658-1662.
[http://dx.doi.org/10.1126/science.7886457] [PMID: 7886457]
[43]
Yamada, K.; Mizuno, M.; Nabeshima, T. Role for brain-derived neurotrophic factor in learning and memory. Life Sci., 2002, 70(7), 735-744.
[http://dx.doi.org/10.1016/S0024-3205(01)01461-8] [PMID: 11833737]
[44]
Egan, M.F.; Kojima, M.; Callicott, J.H.; Goldberg, T.E.; Kolachana, B.S.; Bertolino, A.; Zaitsev, E.; Gold, B.; Goldman, D.; Dean, M.; Lu, B.; Weinberger, D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell, 2003, 112(2), 257-269.
[http://dx.doi.org/10.1016/S0092-8674(03)00035-7] [PMID: 12553913]
[45]
Cathomas, F.; Vogler, C.; Euler-Sigmund, J.C.; de Quervain, D.J.F.; Papassotiropoulos, A. Fine-mapping of the brain-derived neurotrophic factor (BDNF) gene supports an association of the Val66Met polymorphism with episodic memory. Int. J. Neuropsychopharmacol., 2010, 13(8), 975-980.
[http://dx.doi.org/10.1017/S1461145710000519] [PMID: 20482942]
[46]
Xu, B.; Goulding, E.H.; Zang, K.; Cepoi, D.; Cone, R.D.; Jones, K.R.; Tecott, L.H.; Reichardt, L.F. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat. Neurosci., 2003, 6(7), 736-742.
[http://dx.doi.org/10.1038/nn1073] [PMID: 12796784]
[47]
Cao, L.; Lin, E.J.D.; Cahill, M.C.; Wang, C.; Liu, X.; During, M.J. Molecular therapy of obesity and diabetes by a physiological autoregulatory approach. Nat. Med., 2009, 15(4), 447-454.
[http://dx.doi.org/10.1038/nm.1933] [PMID: 19270710]
[48]
Nagahara, A.H.; Tuszynski, M.H. Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat. Rev. Drug Discov., 2011, 10(3), 209-219.
[http://dx.doi.org/10.1038/nrd3366] [PMID: 21358740]
[49]
Ernfors, P.; Wetmore, C.; Olson, L.; Persson, H. Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family. Neuron, 1990, 5(4), 511-526.
[http://dx.doi.org/10.1016/0896-6273(90)90090-3] [PMID: 2206535]
[50]
Hofer, M.; Pagliusi, S.R.; Hohn, A.; Leibrock, J.; Barde, Y.A. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J., 1990, 9(8), 2459-2464.
[http://dx.doi.org/10.1002/j.1460-2075.1990.tb07423.x] [PMID: 2369898]
[51]
Conner, J.M.; Lauterborn, J.C.; Yan, Q.; Gall, C.M.; Varon, S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: Evidence for anterograde axonal transport. J. Neurosci., 1997, 17(7), 2295-2313.
[http://dx.doi.org/10.1523/JNEUROSCI.17-07-02295.1997] [PMID: 9065491]
[52]
Yan, Q.; Rosenfeld, R.D.; Matheson, C.R.; Hawkins, N.; Lopez, O.T.; Bennett, L.; Welcher, A.A. Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system. Neuroscience, 1997, 78(2), 431-448.
[http://dx.doi.org/10.1016/S0306-4522(96)00613-6] [PMID: 9145800]
[53]
Katoh-Semba, R.; Takeuchi, I.K.; Semba, R.; Kato, K. Distribution of brain-derived neurotrophic factor in rats and its changes with development in the brain. J. Neurochem., 1997, 69(1), 34-42.
[http://dx.doi.org/10.1046/j.1471-4159.1997.69010034.x] [PMID: 9202291]
[54]
Gorba, T.; Klostermann, O.; Wahle, P. Development of neuronal activity and activity-dependent expression of brain-derived neurotrophic factor mRNA in organotypic cultures of rat visual cortex. Cereb. Cortex, 1999, 9(8), 864-877.
[http://dx.doi.org/10.1093/cercor/9.8.864] [PMID: 10601005]
[55]
Patz, S.; Wahle, P. Developmental changes of neurotrophin mRNA expression in the layers of rat visual cortex. Eur. J. Neurosci., 2006, 24(9), 2453-2460.
[http://dx.doi.org/10.1111/j.1460-9568.2006.05126.x] [PMID: 17100834]
[56]
Adachi, N.; Numakawa, T.; Richards, M.; Nakajima, S.; Kunugi, H. New insight in expression, transport, and secretion of brain-derived neurotrophic factor: Implications in brain-related diseases. World J. Biol. Chem., 2014, 5(4), 409-428.
[http://dx.doi.org/10.4331/wjbc.v5.i4.409] [PMID: 25426265]
[57]
Aid, T.; Kazantseva, A.; Piirsoo, M.; Palm, K.; Timmusk, T. Mouse and rat BDNF gene structure and expression revisited. J. Neurosci. Res., 2007, 85(3), 525-535.
[http://dx.doi.org/10.1002/jnr.21139] [PMID: 17149751]
[58]
Pruunsild, P.; Kazantseva, A.; Aid, T.; Palm, K.; Timmusk, T. Dissecting the human BDNF locus: Bidirectional transcription, complex splicing, and multiple promoters. Genomics, 2007, 90(3), 397-406.
[http://dx.doi.org/10.1016/j.ygeno.2007.05.004] [PMID: 17629449]
[59]
Barker, P.A. Whither proBDNF? Nat. Neurosci., 2009, 12(2), 105-106.
[http://dx.doi.org/10.1038/nn0209-105] [PMID: 19172162]
[60]
Azimova, J.; Kondratieva, N.; Cepгeeв, A.B. The role of BDNF gene polymorphism in formation of clinical characteristics of migraine. J. Neurol. Stroke, 2016, 4(2)
[http://dx.doi.org/10.15406/jnsk.2016.04.00123]
[61]
Fischer, M.; Wille, G.; Klien, S.; Shanib, H.; Holle, D.; Gaul, C.; Broessner, G. Brain-derived neurotrophic factor in primary headaches. J. Headache Pain, 2012, 13(6), 469-475.
[http://dx.doi.org/10.1007/s10194-012-0454-5] [PMID: 22584531]
[62]
Cai, X.; Shi, X.; Zhang, X.; Zhang, A.; Zheng, M.; Fang, Y. The association between brain-derived neurotrophic factor gene polymorphism and migraine: A meta-analysis. J. Headache Pain, 2017, 18(1), 13.
[http://dx.doi.org/10.1186/s10194-017-0725-2] [PMID: 28150221]
[63]
Lu, B.; Pang, P.T.; Woo, N.H. The yin and yang of neurotrophin action. Nat. Rev. Neurosci., 2005, 6(8), 603-614.
[http://dx.doi.org/10.1038/nrn1726] [PMID: 16062169]
[64]
Minichiello, L.; Trk, B. TrkB signalling pathways in LTP and learning. Nat. Rev. Neurosci., 2009, 10(12), 850-860.
[http://dx.doi.org/10.1038/nrn2738] [PMID: 19927149]
[65]
Matsumoto, T.; Rauskolb, S.; Polack, M.; Klose, J.; Kolbeck, R.; Korte, M.; Barde, Y.A. Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF. Nat. Neurosci., 2008, 11(2), 131-133.
[http://dx.doi.org/10.1038/nn2038] [PMID: 18204444]
[66]
Dieni, S.; Matsumoto, T.; Dekkers, M.; Rauskolb, S.; Ionescu, M.S.; Deogracias, R.; Gundelfinger, E.D.; Kojima, M.; Nestel, S.; Frotscher, M.; Barde, Y.A. BDNF and its pro-peptide are stored in presynaptic dense core vesicles in brain neurons. J. Cell Biol., 2012, 196(6), 775-788.
[http://dx.doi.org/10.1083/jcb.201201038] [PMID: 22412021]
[67]
Edelmann, E.; Leßmann, V.; Brigadski, T. Pre- and postsynaptic twists in BDNF secretion and action in synaptic plasticity. Neuropharmacology, 2014, 76(Pt C), 610-627.
[http://dx.doi.org/10.1016/j.neuropharm.2013.05.043]
[68]
Ernfors, P.; Lee, K.F.; Jaenisch, R. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature, 1994, 368(6467), 147-150.
[http://dx.doi.org/10.1038/368147a0] [PMID: 8139657]
[69]
Lommatzsch, M.; Braun, A.; Mannsfeldt, A.; Botchkarev, V.A.; Botchkareva, N.V.; Paus, R.; Fischer, A.; Lewin, G.R.; Renz, H. Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Am. J. Pathol., 1999, 155(4), 1183-1193.
[http://dx.doi.org/10.1016/S0002-9440(10)65221-2] [PMID: 10514401]
[70]
Fujimura, H.; Chen, R.; Nakamura, T.; Nakahashi, T.; Kambayashi, J.; Sun, B.; Altar, C.; Tandon, N. Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb. Haemost., 2002, 87(4), 728-734.
[http://dx.doi.org/10.1055/s-0037-1613072] [PMID: 12008958]
[71]
Jiang, H.; Chen, S.; Li, C.; Lu, N.; Yue, Y.; Yin, Y.; Zhang, Y.; Zhi, X.; Zhang, D.; Yuan, Y. The serum protein levels of the tPA–BDNF pathway are implicated in depression and antidepressant treatment. Transl. Psychiatry, 2017, 7(4), e1079-e1079.
[http://dx.doi.org/10.1038/tp.2017.43] [PMID: 28375203]
[72]
Borba, E.M.; Duarte, J.A.; Bristot, G.; Scotton, E.; Camozzato, A.L.; Chaves, M.L.F. Brain-derived neurotrophic factor serum levels and hippocampal volume in mild cognitive impairment and dementia due to alzheimer disease. Dement. Geriatr. Cogn. Disord. Extra, 2016, 6(3), 559-567.
[http://dx.doi.org/10.1159/000450601] [PMID: 28101102]
[73]
Galvez-Contreras, A.Y.; Campos-Ordonez, T.; Lopez-Virgen, V.; Gomez-Plascencia, J.; Ramos-Zuniga, R.; Gonzalez-Perez, O. Growth factors as clinical biomarkers of prognosis and diagnosis in psychiatric disorders. Cytokine Growth Factor Rev., 2016, 32, 85-96.
[http://dx.doi.org/10.1016/j.cytogfr.2016.08.004] [PMID: 27618303]
[74]
Autry, A.E.; Monteggia, L.M. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol. Rev., 2012, 64(2), 238-258.
[http://dx.doi.org/10.1124/pr.111.005108] [PMID: 22407616]
[75]
Karege, F.; Schwald, M.; Cisse, M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci. Lett., 2002, 328(3), 261-264.
[http://dx.doi.org/10.1016/S0304-3940(02)00529-3] [PMID: 12147321]
[76]
Sartorius, A.; Hellweg, R.; Litzke, J.; Vogt, M.; Dormann, C.; Vollmayr, B.; Danker-Hopfe, H.; Gass, P. Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry, 2009, 42(6), 270-276.
[http://dx.doi.org/10.1055/s-0029-1224162] [PMID: 19924587]
[77]
Buse, D.C.; Reed, M.L.; Fanning, K.M.; Bostic, R.; Dodick, D.W.; Schwedt, T.J.; Munjal, S.; Singh, P.; Lipton, R.B. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: Results of the migraine in America symptoms and treatment (MAST) study. J. Headache Pain, 2020, 21(1), 23.
[http://dx.doi.org/10.1186/s10194-020-1084-y] [PMID: 32122324]
[78]
Holmuratova, B.; Rashidova, N.; Khalimova, K.; Matmurodov, R.; Rakhmatullaeva, G. The role of BDNF in the clinical course of primary headaches. Cephalalgia Rep., 2023, 6, 25158163231190292.
[http://dx.doi.org/10.1177/25158163231190292]
[79]
Duan, S.; Ren, Z.; Xia, H.; Wang, Z.; Zheng, T.; Li, G.; Liu, L.; Liu, Z. Associations between anxiety, depression with migraine, and migraine-related burdens. Front. Neurol., 2023, 14, 1090878.
[http://dx.doi.org/10.3389/fneur.2023.1090878] [PMID: 37181566]
[80]
Gorka, S.M.; Teppen, T.; Radoman, M.; Phan, K.L.; Pandey, S.C. Human plasma BDNF is associated with amygdala-prefrontal cortex functional connectivity and problem drinking behaviors. Int. J. Neuropsychopharmacol., 2020, 23(1), 1-11.
[http://dx.doi.org/10.1093/ijnp/pyz057] [PMID: 31722379]
[81]
Klein, A.B.; Williamson, R.; Santini, M.A.; Clemmensen, C.; Ettrup, A.; Rios, M.; Knudsen, G.M.; Aznar, S. Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int. J. Neuropsychopharmacol., 2011, 14(3), 347-353.
[http://dx.doi.org/10.1017/S1461145710000738] [PMID: 20604989]
[82]
Altamura, C.; Corbelli, I.; de Tommaso, M.; Di Lorenzo, C.; Di Lorenzo, G.; Di Renzo, A.; Filippi, M.; Jannini, T.B.; Messina, R.; Parisi, P.; Parisi, V.; Pierelli, F.; Rainero, I.; Raucci, U.; Rubino, E.; Sarchielli, P.; Li, L.; Vernieri, F.; Vollono, C.; Coppola, G. Pathophysiological bases of comorbidity in migraine. Front. Hum. Neurosci., 2021, 15, 640574.
[http://dx.doi.org/10.3389/fnhum.2021.640574] [PMID: 33958992]
[83]
Sudershan, A.; Mahajan, K.; Singh, K.; Dhar, M.K.; Kumar, P. The complexities of migraine: A debate among migraine researchers: A review. Clin. Neurol. Neurosurg., 2022, 214, 107136.
[http://dx.doi.org/10.1016/j.clineuro.2022.107136] [PMID: 35101780]
[84]
Zhao, Z.; Jin, H.; Yin, Y.; Hou, Y.; Wang, J.; Tang, C.; Fu, J. Association of migraine with its comorbidities and food specific immunoglobulin g antibodies and inflammatory cytokines: Cross-sectional clinical research. J. Pain Res., 2021, 14, 2359-2368.
[http://dx.doi.org/10.2147/JPR.S316619] [PMID: 34385841]
[85]
Zarneshan, S.N.; Fakhri, S.; Khan, H. Targeting Akt/CREB/BDNF signaling pathway by ginsenosides in neurodegenerative diseases: A mechanistic approach. Pharmacol. Res., 2022, 177, 106099.
[http://dx.doi.org/10.1016/j.phrs.2022.106099] [PMID: 35092819]
[86]
Lima Giacobbo, B.; Doorduin, J.; Klein, H.C.; Dierckx, R.A.J.O.; Bromberg, E.; de Vries, E.F.J. Brain-derived neurotrophic factor in brain disorders: Focus on neuroinflammation. Mol. Neurobiol., 2019, 56(5), 3295-3312.
[http://dx.doi.org/10.1007/s12035-018-1283-6] [PMID: 30117106]
[87]
Szklarczyk, D.; Gable, A.L.; Lyon, D.; Junge, A.; Wyder, S.; Huerta-Cepas, J.; Simonovic, M.; Doncheva, N.T.; Morris, J.H.; Bork, P.; Jensen, L.J.; Mering, C. STRING v11: Protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res., 2019, 47(D1), D607-D613.
[http://dx.doi.org/10.1093/nar/gky1131] [PMID: 30476243]
[88]
Amin, F.M.; Aristeidou, S.; Baraldi, C.; Czapinska-Ciepiela, E.K.; Ariadni, D.D.; Di Lenola, D.; Fenech, C.; Kampouris, K.; Karagiorgis, G.; Braschinsky, M.; Linde, M. The association between migraine and physical exercise. J. Headache Pain, 2018, 19(1), 83.
[http://dx.doi.org/10.1186/s10194-018-0902-y] [PMID: 30203180]
[89]
Neri, L.C.L.; Ferraris, C.; Catalano, G.; Guglielmetti, M.; Pasca, L.; Pezzotti, E.; Carpani, A.; Tagliabue, A. Ketosis and migraine: A systematic review of the literature and meta-analysis. Front. Nutr., 2023, 10, 1204700.
[http://dx.doi.org/10.3389/fnut.2023.1204700] [PMID: 37377485]
[90]
Nourollahimoghadam, E.; Gorji, S.; Gorji, A.; Khaleghi Ghadiri, M. Therapeutic role of yoga in neuropsychological disorders. World J. Psychiatry, 2021, 11(10), 754-773.
[http://dx.doi.org/10.5498/wjp.v11.i10.754] [PMID: 34733640]
[91]
Zhou, C.; Zhong, J.; Zou, B.; Fang, L.; Chen, J.; Deng, X.; Zhang, L.; Zhao, X.; Qu, Z.; Lei, Y.; Lei, T. Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression. PLoS One, 2017, 12(2), e0172270.
[http://dx.doi.org/10.1371/journal.pone.0172270] [PMID: 28241064]
[92]
Kang, M.J.Y.; Hawken, E.; Vazquez, G.H. The mechanisms behind rapid antidepressant effects of ketamine: A systematic review with a focus on molecular neuroplasticity. Front. Psychiatry, 2022, 13, 860882.
[http://dx.doi.org/10.3389/fpsyt.2022.860882] [PMID: 35546951]
[93]
Wei, H.L.; Wei, C.; Feng, Y.; Yan, W.; Yu, Y.S.; Chen, Y.C.; Yin, X.; Li, J.; Zhang, H. Predicting the efficacy of non-steroidal anti-inflammatory drugs in migraine using deep learning and three-dimensional T1-weighted images. iScience, 2023, 26(11), 108107.
[http://dx.doi.org/10.1016/j.isci.2023.108107] [PMID: 37867961]
[94]
Kinreich, S.; McCutcheon, V.V.; Aliev, F.; Meyers, J.L.; Kamarajan, C.; Pandey, A.K.; Chorlian, D.B.; Zhang, J.; Kuang, W.; Pandey, G.; Viteri, S.S.S.; Francis, M.W.; Chan, G.; Bourdon, J.L.; Dick, D.M.; Anokhin, A.P.; Bauer, L.; Hesselbrock, V.; Schuckit, M.A.; Nurnberger, J.I., Jr; Foroud, T.M.; Salvatore, J.E.; Bucholz, K.K.; Porjesz, B. Predicting alcohol use disorder remission: A longitudinal multimodal multi-featured machine learning approach. Transl. Psychiatry, 2021, 11(1), 166.
[http://dx.doi.org/10.1038/s41398-021-01281-2] [PMID: 33723218]
[95]
Peele, K.A.; Potla Durthi, C.; Srihansa, T.; Krupanidhi, S.; Ayyagari, V.S.; Babu, D.J.; Indira, M.; Reddy, A.R.; Venkateswarulu, T.C. Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study. Informatics in Medicine Unlocked, 2020, 19, 100345.
[http://dx.doi.org/10.1016/j.imu.2020.100345] [PMID: 32395606]
[96]
Friesner, R.A.; Banks, J.L.; Murphy, R.B.; Halgren, T.A.; Klicic, J.J.; Mainz, D.T.; Repasky, M.P.; Knoll, E.H.; Shelley, M.; Perry, J.K.; Shaw, D.E.; Francis, P.; Shenkin, P.S. Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem., 2004, 47(7), 1739-1749.
[http://dx.doi.org/10.1021/jm0306430] [PMID: 15027865]
[97]
Loganathan, L.; Muthusamy, K.; Jayaraj, J.M.; Kajamaideen, A.; Balthasar, J.J. In silico insights on tankyrase protein: A potential target for colorectal cancer. J. Biomol. Struct. Dyn., 2019, 37(14), 3637-3648.
[http://dx.doi.org/10.1080/07391102.2018.1521748] [PMID: 30204055]
[98]
Muthusamy, K.; Krishnasamy, G. A computational study on role of 6-(hydroxymethyl)-3-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxan-2-yl]oxyoxane-2,4,5-triol in the regulation of blood glucose level. J. Biomol. Struct. Dyn., 2016, (12), 1-20.
[http://dx.doi.org/10.1080/07391102.2015.1124289]
[99]
Loganathan, L.; Natarajan, K.; Muthusamy, K. Computational study on cross-talking cancer signalling mechanism of ring finger protein 146, AXIN and Tankyrase protein complex. J. Biomol. Struct. Dyn., 2020, 38(17), 5173-5185.
[http://dx.doi.org/10.1080/07391102.2019.1696707] [PMID: 31760854]
[100]
Loganathan, L.; Kuriakose, B.B.; Mushfiq, S.; Muthusamy, K. Mechanistic insights on nsSNPs on binding site of renin and cytochrome P450 proteins: A computational perceptual study for pharmacogenomics evaluation. J. Cell. Biochem., 2021, 122(10), 1460-1474.
[http://dx.doi.org/10.1002/jcb.30069] [PMID: 34161641]
[101]
Jayaraj, J.M.; Kuriakose, B.B.; Alhazmi, A.H.; Muthusamy, K. Structural and functional insights on vitamin D receptor and CYP24A1 deleterious single nucleotide polymorphisms: A computational and pharmacogenomics perpetual approach. Cell Biochem. Funct., 2021, 39(7), 874-885.
[http://dx.doi.org/10.1002/cbf.3658] [PMID: 34231237]
[102]
Gupta, N.; Choudhary, S.K.; Bhagat, N.; Karthikeyan, M.; Chaturvedi, A. In silico prediction, molecular docking and dynamics studies of steroidal alkaloids of holarrhena pubescens wall. ex G. Don to guanylyl cyclase C: Implications in designing of novel antidiarrheal therapeutic strategies. Molecules, 2021, 26(14), 4147.
[http://dx.doi.org/10.3390/molecules26144147] [PMID: 34299422]
[103]
Loganathan, L.; Briget, K.B.; Sampayan, L.E.; Muthusamy, K. Targeting renin receptor for the inhibition of renin angiotensin aldosterone system: An alternative approach through in silico drug discovery. Comput. Theor. Chem., 2022, 1208, 113541-113541.
[http://dx.doi.org/10.1016/j.comptc.2021.113541]
[104]
Jayaraj, J.M.; Reteti, E.; Kesavan, C.; Muthusamy, K. Structural insights on vitamin D receptor and screening of new potent agonist molecules: Structure and ligand-based approach. J. Biomol. Struct. Dyn., 2021, 39(11), 4148-4159.
[http://dx.doi.org/10.1080/07391102.2020.1775122] [PMID: 32462983]
[105]
John Marshal, J.; Kuriakose, B.B.; Alhazmi, A.H.; Muthusamy, K. Mechanistic insights into the role of vitamin D and computational identification of potential lead compounds for Parkinson’s disease. J. Cell. Biochem., 2023, 124(3), 434-445.
[http://dx.doi.org/10.1002/jcb.30379] [PMID: 36780350]
[106]
Kandasamy, S.; Selvaraj, M.; Muthusamy, K.; Varadaraju, N.; Kannupal, S.; Sekar, A.K.; Vilwanathan, R. Structural exploration of common pharmacophore based berberine derivatives as novel histone deacetylase inhibitor targeting HDACs enzymes. J. Biomol. Struct. Dyn., 2022, 1-14.
[http://dx.doi.org/10.1080/07391102.2021.2024254] [PMID: 34994284]
[107]
Chinnasamy, S.; Nagamani, S.; Muthusamy, K. Zn 2+ ion of the snake venom metalloproteinase (SVMP) plays a critical role in ligand binding: A molecular dynamics simulation study. RSC Advances, 2015, 5(86), 70566-70576.
[http://dx.doi.org/10.1039/C5RA14693C]
[108]
Ramakrishnan, P. Pandiselvi Pandi; Muralidharan Jothimani; Sakthi Sasikala Sundaravel; Karthikeyan Muthusamy; Narayanan, U.; Mehboobali Pannipara; Al-Sehemi, A.G.; Jayaraman, A. Computational Approach on Moringa Oleifera as an Inhibitor against SARS-CoV-2 Structural Proteins. Indian Journal of Biochemistry and Biophysics (IJBB)., 2023, 60(12), 941-957.
[http://dx.doi.org/10.56042/ijbb.v60i12.6278]

© 2024 Bentham Science Publishers | Privacy Policy